,42 Here, we demonstrate that a novel process of dynamic NKG2D expression by both CD4– and CD4+ iNKT cell subsets allows targeting of leukemia cells with variable expression of CAR antigens more efficiently than by CAR T cells, in an NKG2D-dependent manner. The gene discussed is KLRK1; the disease is leukemia.